Mersana Therapeutics, Inc.
They are a clinical stage biopharmaceutical company focused on developing antibody drug conjugates, or ADCs, that offer a clinically meaningful benefit for cancer patients with significant unmet need.
$14.00 - $16.00
J.P. Morgan, Cowen and Company, Leerink Partners, Wedbush PacGrow
To view the prospectus for Mersana Therapeutics, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277